GSK Chairman Philip Hampton to step down ahead of split
Britain's largest drugmaker GlaxoSmithKline's (GSK) Chairman Philip Hampton will step down after over three and a half years in the role. This comes following an announcement by the drugmaker's CEO Emma Walmsley to split the company into two through a joint venture with US rival Pfizer. Before joining GSK, Hampton served as the Chairman of Royal Bank of Scotland Group.